- Invirase and PPIs
- Updated Resistance Profile
- Patient Assistance
- Healthcare Professionals Resources
- Complete Product Information
Patient Assistance
Roche Laboratories is committed to helping healthcare providers and patients gain access to Roche products such as boosted INVIRASE. As a service to both healthcare providers and their patients, Roche Laboratories offers the Roche HIV Therapy Assistance Program, which is available through the ASSIST™ Reimbursement Hotline at 1-800-282-7780.
ASSIST™ Reimbursement Hotline
1-800-282-7780
Monday through Friday: 9:00 am to 8:00 pm Eastern Standard Time (EST)
The Roche HIV Therapy Assistance Program is a service provided by Roche Laboratories.
Reimbursement Support Services
Every insurance company and public healthcare program has its own coverage and reimbursement procedures for various Roche HIV products. The Roche HIV Therapy Assistance Program is staffed by reimbursement specialists trained to answer questions about insurance coverage. When you call the ASSIST Reimbursement Hotline, a specialist will help you understand individual insurance requirements and the procedures necessary to get coverage.
[ Back to Top ]
How the Program Can Help
The Roche HIV Therapy Assistance Program offers a range of services to patients and healthcare providers, including:
- Providing information about insurance coverage policies for Roche HIV products, whether the policies are for private insurance plans like HMOs or public programs like Medicaid or AIDS Drug Assistance Programs (ADAPs)
- Identifying sources of help for handling coverage problems
- Providing information on prior authorizations, claim submissions and other procedures
- Answering questions about claim denials and appeals processes
- Qualification and enrollment of eligible patients in the Medical Needs Program
Although the program provides direct assistance on individual claims problems, it cannot guarantee coverage or a specific reimbursement rate for Roche products.
[ Back to Top ]
The Medical Needs Program
Outpatients who have been prescribed INVIRASE® (saquinavir mesylate), Fuzeon® (enfuvirtide), Valcyte® (valganciclovir HCl), or Fortovase® (saquinavir), but don’t have prescription coverage or assistance and can’t afford to get the medicine should ask their doctor, case manager or other healthcare professional to contact the Medical Needs Program.
This program works with patients and physicians to locate sources of help in dealing with insurance coverage problems with the medicines Fortovase, Valcyte, INVIRASE, and Fuzeon. In addition, the Medical Needs Program helps obtain access to those drugs for eligible patients who are unable to obtain prescription drug coverage.
[ Back to Top ]
To Enroll in the Medical Needs Program
- Healthcare providers should call the Roche ASSIST Reimbursement Hotline at 1-800-282-7780
- The reimbursement specialist will take all the needed information during the call, then send an enrollment form to the healthcare provider
- The healthcare provider and patient must both sign the application form. The doctor will need to include a prescription. The patient must submit proof of financial and insurance status, if requested. The application and additional documentation must be returned to the Medical Needs Program by mail
- Once the form and documentation are received, a reimbursement specialist will determine if the patient is eligible
- The healthcare provider will be notified of the patient’s eligibility
- For eligible patients, Roche will send the first shipment of medication directly to the healthcare provider’s office within 5 business days
Completion of an application does not guarantee qualification for free medicine.
[ Back to Top ]
For More Information
For further information on the Roche HIV Therapy Assistance Program, call the ASSIST Reimbursement Hotline at 1-800-282-7780 Monday through Friday, 9:00 am to 8:00 pm Eastern Standard Time (EST).
Roche reserves the right to change or discontinue any or all portions of the Roche HIV Therapy Asisstance Program or the Medical Needs Program at any time.
Third-party reimbursement is affected by many factors. Therefore, Roche Laboratories makes no representation or guarantee that patients will be successful in obtaining insurance reimbursement or any other payment. Moreover, the Roche HIV Therapy Assistance Program is provided as an information service. Roche makes great efforts to provide up-to-date information; however, Roche makes no representations or warranties, express or implied, as to the accuracy of this information. All users agree that all use of this service is at their own risk.
[ Back to Top ]
